These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prostate cancer: Usefulness of 18F-fluciclovine PET/CT in the detection and differential diagnosis of an early bone metastasis for successful treatment with radio-guided stereotactic ablative radiotherapy. Cassou-Mounat T; Krhili SL; Luporsi M; Amiot HM; Huchet V; Jehanno N Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):318-320. PubMed ID: 32305307 [No Abstract] [Full Text] [Related]
23. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for Kim EH; Siegel BA; Teoh EJ; Andriole GL; Urol Oncol; 2021 Jun; 39(6):365.e9-365.e16. PubMed ID: 33160848 [TBL] [Abstract][Full Text] [Related]
24. Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy. Lawal IO; Marcus C; Schuster DM; Goyal S; Adediran OA; Dhere VR; Joshi SS; Abiodun-Ojo OA; Master VA; Patel PR; Fielder B; Goodman M; Shelton JW; Kucuk O; Hershatter B; Halkar RK; Jani AB Clin Nucl Med; 2023 Apr; 48(4):e153-e159. PubMed ID: 36754362 [TBL] [Abstract][Full Text] [Related]
25. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970 [TBL] [Abstract][Full Text] [Related]
27. The Clinical Utility of Nakamoto R; Harrison C; Song H; Guja KE; Hatami N; Nguyen J; Moradi F; Franc BL; Aparici CM; Davidzon G; Iagaru A Mol Imaging Biol; 2021 Aug; 23(4):614-623. PubMed ID: 33469884 [TBL] [Abstract][Full Text] [Related]
28. Patterns of Recurrence, Detection Rates, and Impact of 18-F Fluciclovine PET/CT on the Management of Men With Recurrent Prostate Cancer. Michael J; Khandani AH; Basak R; Tan HJ; Royce TJ; Wallen E; Whang Y; Rose TL; Milowsky M; Bjurlin MA Urology; 2021 Sep; 155():192-198. PubMed ID: 33516829 [TBL] [Abstract][Full Text] [Related]
29. Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment? Teyateeti A; Teyateeti A; Macapinlac HA; Lu Y Clin Nucl Med; 2020 Sep; 45(9):672-678. PubMed ID: 32604105 [TBL] [Abstract][Full Text] [Related]
30. Fluorine-18-Labeled Fluciclovine PET/CT in Primary and Biochemical Recurrent Prostate Cancer Management. Marcus C; Butler P; Bagrodia A; Cole S; Subramaniam RM AJR Am J Roentgenol; 2020 Aug; 215(2):267-276. PubMed ID: 32551903 [No Abstract] [Full Text] [Related]
31. Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using Miller MP; Kostakoglu L; Pryma D; Yu JQ; Chau A; Perlman E; Clarke B; Rosen D; Ward P J Nucl Med; 2017 Oct; 58(10):1596-1602. PubMed ID: 28385791 [No Abstract] [Full Text] [Related]
32. Utility of Wang Y; Chow DZ; Ebert E; Tajmir S; Scott JA; Palmer EL AJR Am J Roentgenol; 2020 Oct; 215(4):997-1001. PubMed ID: 32569513 [No Abstract] [Full Text] [Related]
33. Comparison of Diagnostic Utility of Fluciclovine PET/CT Versus Pelvic Multiparametric MRI for Prostate Cancer in the Pelvis in the Setting of Rising PSA After Initial Treatment. Chen B; Bathala TK; Xu G; Teyateeti A; Chapin BF; Tang C; Tu SM; Macapinlac HA; Lu Y Clin Nucl Med; 2020 May; 45(5):349-355. PubMed ID: 31977495 [TBL] [Abstract][Full Text] [Related]
39. First case of 18F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative 11C-choline PET/CT: new imaging techniques may expand pioneering approaches. Schiavina R; Concetti S; Brunocilla E; Nanni C; Borghesi M; Gentile G; Cevenini M; Bianchi L; Molinaroli E; Fanti S; Martorana G Urol Int; 2014; 92(2):242-5. PubMed ID: 24334968 [TBL] [Abstract][Full Text] [Related]